^"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
^"Drug Information Portal - U.S. National Library of Medicine - Quick Access to Quality Drug Information". druginfo.nlm.nih.gov. Retrieved 9 January 2021.
^"Optiray (ioversol) dosing, indications, interactions, adverse effects, and more". reference.medscape.com. Retrieved 9 January 2021.
^Chen Y, Huang X, Huang S, Matchett M (17 February 2011). "13. Fast-in-process method for the determination ioversol and related polar compounds by hydrophilic interactive chromatography". In Wang PG, He W (eds.). Hydrophilic Interaction Liquid Chromatography (HILIC) and Advanced Applications. CRC Press. p. 295-30. ISBN978-1-4398-0753-8.
ioversol, trade, name, optiray, organoiodine, compound, that, used, contrast, medium, features, both, high, iodine, content, well, several, hydrophilic, groups, used, clinical, diagnostics, including, arthrography, angiocardiography, urography, clinical, datat. Ioversol INN trade name Optiray is an organoiodine compound that is used as a contrast medium It features both a high iodine content as well as several hydrophilic groups It is used in clinical diagnostics including arthrography angiocardiography and urography 2 3 4 IoversolClinical dataTrade namesOptirayAHFS Drugs comMultum Consumer InformationPregnancycategoryAU B1ATC codeV08AB07 WHO Legal statusLegal statusAU Unscheduled US WARNING 1 Pharmacokinetic dataProtein bindingLowMetabolismNoneElimination half life90 minExcretionKidneysIdentifiersIUPAC name 1 N 3 N bis 2 3 dihydroxypropyl 5 2 hydroxy N 2 hydroxyethyl acetamido 2 4 6 triiodobenzene 1 3 dicarboxamideCAS Number87771 40 2 YPubChem CID3741DrugBankDB09134 YChemSpider3610 NUNIIN3RIB7X24KKEGGD01555 YChEMBLChEMBL1200614 NCompTox Dashboard EPA DTXSID2045521ECHA InfoCard100 118 911Chemical and physical dataFormulaC 18H 24I 3N 3O 9Molar mass807 115 g mol 13D model JSmol Interactive imageSMILES C CO N C1 C C C C C1I C O NCC CO O I C O NCC CO O I C O COInChI InChI 1S C18H24I3N3O9 c19 13 11 17 32 22 3 8 29 5 26 14 20 16 24 1 2 25 10 31 7 28 15 21 12 13 18 33 23 4 9 30 6 27 h8 9 25 30H 1 7H2 H 22 32 H 23 33 NKey AMDBBAQNWSUWGN UHFFFAOYSA N N N Y what is this verify References edit FDA sourced list of all drugs with black box warnings Use Download Full Results and View Query links nctr crs fda gov FDA Retrieved 22 Oct 2023 Drug Information Portal U S National Library of Medicine Quick Access to Quality Drug Information druginfo nlm nih gov Retrieved 9 January 2021 Optiray ioversol dosing indications interactions adverse effects and more reference medscape com Retrieved 9 January 2021 Chen Y Huang X Huang S Matchett M 17 February 2011 13 Fast in process method for the determination ioversol and related polar compounds by hydrophilic interactive chromatography In Wang PG He W eds Hydrophilic Interaction Liquid Chromatography HILIC and Advanced Applications CRC Press p 295 30 ISBN 978 1 4398 0753 8 Portal nbsp Medicine nbsp This pharmacology related article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title Ioversol amp oldid 1149327765, wikipedia, wiki, book, books, library,